ANGO logo

ANGO

AngioDynamics, Inc.NASDAQHealthcare
$10.31-13.65%ClosedMarket Cap: $425.0M

As of 2026-04-06

Valuation

View Details

P/E (TTM)

PEG

P/B

2.36

P/S

1.29

EV/EBITDA

-54.00

DCF Value

$2.68

FCF Yield

0.4%

Div Yield

0.0%

Margins & Returns

Gross Margin

53.5%

Operating Margin

-7.2%

Net Margin

-10.0%

ROE

-17.6%

ROA

-12.0%

ROIC

-11.7%

Financials

View All
PeriodRevenueNet IncomeEPS
Q3 2026$78.4M$-8.1M$-0.19
Q2 2026$79.4M$-6.3M$-0.15
Q1 2026$75.7M$-10.9M$-0.26
Q4 2025$80.2M$-6.0M$-0.15

Analyst Ratings

View All
Canaccord GenuityBuy
2025-10-03
HC Wainwright & Co.Buy
2025-07-16
Canaccord GenuityBuy
2025-07-16
HC Wainwright & Co.Buy
2025-04-07

Trading Activity

Insider Trades

View All
Weiss Lawrence Tofficer: SVP, Chief Legal Officer
BuyWed Oct 22
Trowbridge Stephen Aofficer: EVP and CFO
BuyTue Oct 14
Clemmer James Cdirector, officer: President and CEO
BuyThu Oct 09
Trowbridge Stephen Aofficer: EVP and CFO
SellTue Jul 22
Trowbridge Stephen Aofficer: EVP and CFO
SellTue Jul 22

Company Info

Sector

Healthcare

Industry

Country

US

Exchange

NASDAQ

Beta

0.45

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides endovascular therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies that are used primarily to deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.

Peers